Form D — Tinos Therapeutics, Inc.
0002088485-25-000001 · filed Sep 26, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $1,500,000
- Reported amount sold
- $1,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Tinos Therapeutics, Inc.
- CIK
- 2088485
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 700 MAIN STREET
CAMBRIDGE, MA 02139 - Phone
- 570-939-7415
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Nikolaos Tapinos · Executive OfficerBarrington, RI Find on LinkedIn ↗
-
David Karambizi · Executive OfficerBarrington, RI Find on LinkedIn ↗
-
Anastasios Polimenakos · DirectorBarrington, RI Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗